FI863040A - SAETT ATT FRAMSTAELLA NYA 4-OH-CARBOXYL-QUINOL SYRADERIVES, VILKA AER SUBSTITUERADE I 2-STAELLNINGEN MED EN DIHYDROXYL INNEHAOLLANDE GRUPP, VILKEN EVENTUELLT AER ETERISERAD ELLER FOERESTRAD. - Google Patents

SAETT ATT FRAMSTAELLA NYA 4-OH-CARBOXYL-QUINOL SYRADERIVES, VILKA AER SUBSTITUERADE I 2-STAELLNINGEN MED EN DIHYDROXYL INNEHAOLLANDE GRUPP, VILKEN EVENTUELLT AER ETERISERAD ELLER FOERESTRAD. Download PDF

Info

Publication number
FI863040A
FI863040A FI863040A FI863040A FI863040A FI 863040 A FI863040 A FI 863040A FI 863040 A FI863040 A FI 863040A FI 863040 A FI863040 A FI 863040A FI 863040 A FI863040 A FI 863040A
Authority
FI
Finland
Prior art keywords
aer
syraderives
staellningen
foerestrad
eteriserad
Prior art date
Application number
FI863040A
Other languages
Finnish (fi)
Other versions
FI86426B (en
FI863040A0 (en
FI86426C (en
Inventor
Francois Clemence
Martret Odile Le
Francoise Delevallee
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI863040A0 publication Critical patent/FI863040A0/en
Publication of FI863040A publication Critical patent/FI863040A/en
Publication of FI86426B publication Critical patent/FI86426B/en
Application granted granted Critical
Publication of FI86426C publication Critical patent/FI86426C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compounds of formula (I): <IMAGE> in which X at 5, 6, 7 or 8 is H, halogen, (C1-5) alkyl, (C1-4) alkoxy, -CF3, -SCF3, -OCF3, R1 is phenyl optionally substituted by at least OH, (C1-5) alkyl, (C1-4) alkoxy, CF3, NO2, halogen or a heterocyclic radical optionally substituted by a (C1-4) alkyl radical, R2 and R3 which are identical or different are H, (C1-4) alkyl, aryl, -C(:O)-R5, R5 being (C1-4) alkyl or aryl. R4 is H, (C1-4) alkyl or aryl, and their addition salts with acids and bases.
FI863040A 1985-07-25 1986-07-24 Process for the preparation of novel therapeutically useful 4-OH-quinol incarboxylic acid derivatives FI86426C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8511389A FR2585356B1 (en) 1985-07-25 1985-07-25 NOVEL DERIVATIVES OF 4-OH QUINOLEINE CARBOXYLIC ACID SUBSTITUTED IN 2 BY TWO POSSIBLE ETHERIFIED OR ESTERIFIED HYDROXYL FUNCTIONS, THEIR PREPARATION PROCESSES, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS
FR8511389 1985-07-25

Publications (4)

Publication Number Publication Date
FI863040A0 FI863040A0 (en) 1986-07-24
FI863040A true FI863040A (en) 1987-01-26
FI86426B FI86426B (en) 1992-05-15
FI86426C FI86426C (en) 1992-08-25

Family

ID=9321642

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863040A FI86426C (en) 1985-07-25 1986-07-24 Process for the preparation of novel therapeutically useful 4-OH-quinol incarboxylic acid derivatives

Country Status (16)

Country Link
EP (1) EP0214004B1 (en)
JP (1) JPH0710863B2 (en)
KR (1) KR940003759B1 (en)
AT (1) ATE87625T1 (en)
AU (1) AU609377B2 (en)
CA (1) CA1262903A (en)
DE (1) DE3688161T2 (en)
DK (1) DK172034B1 (en)
ES (1) ES2000739A6 (en)
FI (1) FI86426C (en)
FR (1) FR2585356B1 (en)
GR (1) GR861924B (en)
HU (1) HU202526B (en)
PT (1) PT83064B (en)
SU (1) SU1584749A3 (en)
ZA (1) ZA865260B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
US5438344A (en) * 1990-11-05 1995-08-01 Oliva; Anthony Portable video book
GB9108547D0 (en) * 1991-04-22 1991-06-05 Fujisawa Pharmaceutical Co Quinoline derivatives
AU3339797A (en) * 1996-06-20 1998-01-07 Smithkline Beecham Plc 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
JP3337992B2 (en) * 1997-11-04 2002-10-28 ファイザー製薬株式会社 5-Substituted picolinic acid compound and method for producing the same
JP4804590B1 (en) 2010-04-14 2011-11-02 帝人テクノプロダクツ株式会社 Meta-type wholly aromatic polyamide fiber

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS593996B2 (en) * 1975-11-25 1984-01-27 キツセイ薬品工業株式会社 2-styryl-3,1-benzoxazin-4-one derivative and method for producing the same
JPS593995B2 (en) * 1975-12-31 1984-01-27 キツセイヤクヒンコウギヨウ カブシキガイシヤ 2- Styryl -3,1- Benzoxazine -4-
FR2509728A1 (en) * 1981-07-17 1983-01-21 Roussel Uclaf NOVEL QUINOLINE DERIVATIVES, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME
FR2530633A1 (en) * 1982-06-03 1984-01-27 Roussel Uclaf NOVEL SUBSTITUTED 2-SUBSTITUTED 4-HYDROXY 3-QUINOLINE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION, THEIR USE AS A MEDICINAL PRODUCT, AND THE COMPOSITIONS COMPRISING THE SAME
FR2566405B1 (en) * 1984-06-25 1986-09-26 Roussel Uclaf NOVEL DERIVATIVES OF 4-HYDROXY 3-QUINOLEINE CARBOXYLIC ACID SUBSTITUTED IN 2 BY AN AMINE FUNCTION, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE INTERMEDIATES NEW OBTAINED
ZA871658B (en) * 1986-03-27 1987-08-28 Warner-Lambert Company Chewing gum and confectionery compositions containing a soy flavor enhancer

Also Published As

Publication number Publication date
FR2585356B1 (en) 1987-10-23
FI86426B (en) 1992-05-15
DE3688161D1 (en) 1993-05-06
ZA865260B (en) 1987-09-30
EP0214004B1 (en) 1993-03-31
EP0214004A3 (en) 1989-04-05
PT83064A (en) 1986-08-01
FI863040A0 (en) 1986-07-24
DK172034B1 (en) 1997-09-22
ES2000739A6 (en) 1988-03-16
AU6050986A (en) 1987-01-29
JPS6229585A (en) 1987-02-07
SU1584749A3 (en) 1990-08-07
FR2585356A1 (en) 1987-01-30
EP0214004A2 (en) 1987-03-11
DK351886D0 (en) 1986-07-24
HUT43598A (en) 1987-11-30
CA1262903A (en) 1989-11-14
DK351886A (en) 1987-01-26
FI86426C (en) 1992-08-25
AU609377B2 (en) 1991-05-02
PT83064B (en) 1989-02-28
HU202526B (en) 1991-03-28
KR870001206A (en) 1987-03-12
ATE87625T1 (en) 1993-04-15
GR861924B (en) 1986-11-25
KR940003759B1 (en) 1994-04-30
JPH0710863B2 (en) 1995-02-08
DE3688161T2 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
FI864926A (en) FOTOINITIATORER FOER FOTOPOLYMERISATION AV OMAETTADE SYSTEM.
FI871360A (en) NYA FENOXIALKYLKARBOXYLSYRADERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH LAEKEMEDEL INNEHAOLLANDE DESSA FOERENINGAR.
FI863040A (en) SAETT ATT FRAMSTAELLA NYA 4-OH-CARBOXYL-QUINOL SYRADERIVES, VILKA AER SUBSTITUERADE I 2-STAELLNINGEN MED EN DIHYDROXYL INNEHAOLLANDE GRUPP, VILKEN EVENTUELLT AER ETERISERAD ELLER FOERESTRAD.
FI834730A0 (en) 1-CARBOXYKANOYLPERHYDRO-INDOL-2-CARBOXYLSYROR OR DERIVATIVES
SE8503415L (en) NEW ISOINDOLINYLALKYL PIPERAZINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FI862909A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA INDOLKARBOXAMIDDERIVAT OCH DERAS SALTER.
FI892681A0 (en) NYA JODADE ICKE-JONISKA TRIJODBENZENFOERENINGAR OCH DESSA INNEHAOLLANDE KONTRASTMEDEL.
ES542393A0 (en) &#34;4- (NITROFENIL) -TETRAHIDROPIRIDINAS, PROCEDURE FOR ITS OBTAINING AND ITS USE AS A MEDICINAL PRODUCT&#34;
FI863150A0 (en) NYA TETRAOXOFOERENINGAR.
FI941650A (en) New fluoroquinoline-3-carboxylic acid derivatives and their preparation
DE3679059D1 (en) 5- OR 6-SUBSTITUTED-BETA-CARBOLIN-3-CARBONIC ACID ESTERS.
FI865057A0 (en) NYA FLUORHALTIGA 1,4-DIHYDROPYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
DK280883D0 (en) ORGANOPHOSPHATE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THEIR USE AS MEASURES TO COMPLETE HARMFUL ORGANISMS
SE8704551L (en) NEW BENSO (G) QUINOLINES
DE59206592D1 (en) Process for the preparation of sulfonylureas
FI833971A (en) NYA SEMIKARBAZIDER, DERAS FRAMSTAELLNING OCH ANVAENDNING
DK320582A (en) SUBSTITUTED PHENYL-CYCLOPROPANCARBOXYL ACID ESTERS, PROCEDURES FOR THE PREPARATION OF THEM AND THEIR USE AS MEASURES TO COMPLETE HARMFUL ORGANISMS
FI882332A (en) ANTIARRYTMIS MEDEL.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL

MM Patent lapsed

Owner name: AVENTIS PHARMA S.A.